The phase 4 study of the tacrolimus ointment 0.03% in Infant and toddler patients with Atopic dermatitis
Phase 4
Recruiting
- Conditions
- Atopic dermatitis
- Registration Number
- JPRN-jRCT2031230181
- Lead Sponsor
- ishiura Tomoyuki
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Patients with mild or higher atopic dermatitis aged between 6 months and 2 years.
Exclusion Criteria
- medical history and/or concomitant disease of malignancy, serious allegies, allegy to tacrolimus or skin hypersensitivity to topical medicinal products.
- serious complication of any cardiac, hepatic, renal, pulmonary, hematological disorder etc, which is considered inappropriate to participate in the trial by investigators.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method EASI
- Secondary Outcome Measures
Name Time Method